"Mannose-Binding Lectins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of lectins that are specific for CARBOHYDRATES that contain MANNOSE.
| Descriptor ID |
D037241
|
| MeSH Number(s) |
D12.776.503.311
|
| Concept/Terms |
Mannose-Binding Lectins- Mannose-Binding Lectins
- Lectins, Mannose-Binding
- Mannose Binding Lectins
- Mannose-Specific Lectin
- Lectin, Mannose-Specific
- Mannose Specific Lectin
|
Below are MeSH descriptors whose meaning is more general than "Mannose-Binding Lectins".
Below are MeSH descriptors whose meaning is more specific than "Mannose-Binding Lectins".
This graph shows the total number of publications written about "Mannose-Binding Lectins" by people in this website by year, and whether "Mannose-Binding Lectins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 2 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 3 | 3 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mannose-Binding Lectins" by people in Profiles.
-
Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells. Blood Adv. 2020 01 14; 4(1):87-99.
-
Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis. Nanomedicine (Lond). 2019 02; 14(4):387-406.
-
Beneficial Effects of Prebiotic Saccharomyces cerevisiae Mannan on Allergic Asthma Mouse Models. J Immunol Res. 2017; 2017:3432701.
-
Redox biology of Leishmania and macrophage targeted nanoparticles for therapy. Nanomedicine (Lond). 2017 Jul; 12(14):1713-1725.
-
Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults. Blood. 2017 07 13; 130(2):167-175.
-
Langerhans Cell Histiocytosis: Emerging Insights and Clinical Implications. Oncology (Williston Park). 2016 Feb; 30(2):122-32, 139.
-
Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X? Br J Haematol. 2015 Apr; 169(1):3-13.
-
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med. 2014 Apr 07; 211(4):669-83.
-
Characterization of cells expressing lymphatic marker LYVE-1 in macaque large intestine during simian immunodeficiency virus infection identifies a large population of nonvascular LYVE-1(+)/DC-SIGN(+) cells. Lymphat Res Biol. 2013 Mar; 11(1):26-34.
-
Neither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesions. Mol Ther. 2011 Aug; 19(8):1433-9.